Westfuller Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Westfuller Advisors's REGN Position: Q2 2026 in Review
Westfuller Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 14% in Q2 2026, selling an estimated $2.72K and leaving 24 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #420.
Westfuller Advisors first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $21.7K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Westfuller Advisors held 24 shares of Regeneron Pharmaceuticals worth $15K as of Q2 2026.
- Westfuller Advisors sold 4 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
- Regeneron Pharmaceuticals made up 0.01% of Westfuller Advisors's portfolio in Q2 2026, its #420 holding.
- Westfuller Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Westfuller Advisors's Regeneron Pharmaceuticals position peaked at $21.7K in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.